Diaphragm Morphology and Respiratory Muscle Strength in Subacute Hemiplegic Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorFenerbahce University
About this trial
The aim of this study is to determine the relationship between diaphragm morphology (diaphragm excursion, end-inspiratory and end-expiratory diaphragm thickness, and thickening fraction) and respiratory muscle strength (maximum inspiratory pressure - MIP and maximum expiratory pressure - MEP) in patients with subacute hemiplegia.
Eligibility criteria
Qualifiers
Adults aged 18-80 years
Clinical diagnosis of hemiplegia
Subacute phase (1-6 months post-onset)
Ability to tolerate diaphragm ultrasonography and MIP/MEP measurements
Disqualifiers
Respiratory comorbidities such as COPD, asthma, or interstitial lung disease
Diaphragmatic paralysis or severe chest wall deformity
Acute cardiopulmonary conditions preventing respiratory function testing
Severe cognitive impairment that may affect measurements
Trial design
Treatments tested in this trial
- Not listed
Trial groups
38 Participants
are grouped into 1 trial groupLocations
1Fenerbahçe University34758, IstanbulAtaşehir, Turkey (Türkiye)
Sponsors and collaborators
Fenerbahce University
Lead sponsor
Source ClinicalTrials.gov